C07C 323/67
Containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
Official title: containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton
C07C323/67 (Containing sulfur atoms of sulfonamide groups, bound to the carbon skeleton) appears on 147 US grants and 99 published applications in this corpus.
Search patents in C07C- Granted patents
- 147
- Published applications
- 99
- Assignees
- 73
- Inventors
- 356
- Latest grant
- 20 May 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 2 | 0 |
| 1992 | 5 | 0 |
| 1993 | 2 | 0 |
| 1994 | 2 | 0 |
| 1995 | 3 | 0 |
| 1996 | 0 | 0 |
| 1997 | 5 | 0 |
| 1998 | 4 | 0 |
| 1999 | 6 | 0 |
| 2000 | 9 | 0 |
| 2001 | 6 | 0 |
| 2002 | 10 | 10 |
| 2003 | 8 | 4 |
| 2004 | 5 | 7 |
| 2005 | 7 | 8 |
| 2006 | 3 | 5 |
| 2007 | 4 | 5 |
| 2008 | 5 | 3 |
| 2009 | 3 | 5 |
| 2010 | 4 | 7 |
| 2011 | 4 | 4 |
| 2012 | 5 | 5 |
| 2013 | 6 | 7 |
| 2014 | 6 | 5 |
| 2015 | 3 | 2 |
| 2016 | 4 | 3 |
| 2017 | 4 | 4 |
| 2018 | 2 | 1 |
| 2019 | 4 | 3 |
| 2020 | 2 | 3 |
| 2021 | 2 | 2 |
| 2022 | 1 | 2 |
| 2023 | 1 | 1 |
| 2024 | 2 | 2 |
| 2025 | 1 | 0 |
| 2026 | 0 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cytotoxic and anti-mitotic compounds, and methods of using the same20 May 2025US 12,303,544 B2Zymeworks BC Inc.
- Small molecule direct inhibitors of KEAP1-NRF2 protein-protein interaction22 Oct 2024US 12,122,742 B2Rutgers, The State University of New Jersey
- Pre-assembled, protected, chemically stable, chemoselective linkers16 Jul 2024US 12,037,311 B2Cowper Sciences Inc.
- Cytotoxic and anti-mitotic compounds, and methods of using the same4 Apr 2023US 11,617,777 B2Zymeworks BC Inc.
- N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors19 Apr 2022US 11,306,056 B2Cardioxyl Pharmaceuticals, Inc.
- Compositions and Methods for Modulating the Effect of Beta-Blocker Activity in a Subject12 Mar 2026US 2026/0069555 A1Duke University
- Onium Salt, Resist Composition, And Patterning Process6 Jun 2024US 2024/0184199 A1Shin-Etsu Chemical Co., Ltd.
- Carbonic anhydrase inhibitors synthesized on interconnecting linker chains4 Jan 2024US 2024/0000946 A1Vilnius University
- Cytotoxic and anti-mitotic compounds, and methods of using the same7 Dec 2023US 2023/0390354 A1Zymeworks BC Inc.
- Compounds with antimicrobial activity8 Dec 2022US 2022/0388953 A1The Hong Kong Polytechnic University
Most cited
By later US patents
- α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors56US 6,248,775 B1G. D. Searle & Co. · 2001
- Sulfonamide and carboxamide derivatives and drugs containing the same as the active ingredient54US 6,448,290 B1Ono Pharmaceutical Co., Ltd. · 2002
- Monoesters of probucol for the treatment of cardiovascular and inflammatory disease47US 6,121,319 AAtheroGenics, Inc. · 2000
- Benzoylguanidines, a process for their preparation, their use as medicaments and medicaments containing them45US 5,091,394 AHoechst Aktiengesellschaft · 1992
- .alpha.-and .beta.-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors43US 5,843,946 AG. D. Searle & Co. · 1998